OPEN END TURBO SHORT WARRANT - ROCHE GS Share Price

Certificat

DE000SR7P227

Real-time Boerse Frankfurt Warrants 06:04:50 17/05/2024 pm IST
12.56 EUR -0.16% Intraday chart for OPEN END TURBO SHORT WARRANT - ROCHE GS
Current month-11.03%
1 month-12.03%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/24/17 12.56 -0.16%
16/24/16 12.58 -5.34%
15/24/15 13.29 -2.71%
14/24/14 13.66 +2.78%
13/24/13 13.29 -2.85%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 06:04 pm IST

More quotes

Static data

Product typeKnock-Out con Stop Loss
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
WKN SR7P22
ISINDE000SR7P227
Date issued 27/04/2020
Strike 359 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 10.17
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 15.79
Lowest since issue 0.85
Spread 0.01
Spread %0.08%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
234.8 CHF
Average target price
279.4 CHF
Spread / Average Target
+18.99%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW